Advocates cheer OTC approval for Narcan, but questions remain about price, insurance - The Boston Globe

But questions remain about how the decision will affect access in states such as Massachusetts where naloxone is already widely available behind the pharmacy counter, for little or no cost to consumers. Over-the-counter drugs are not usually covered by insurance, and the manufacturer has not announced a price. The FDA said its decision will allow the drug to be sold without a prescription “directly to consumers in places such as drug stores, convenience stores, grocery stores, and gas stations, as well as online.” The US Food and Drug Administration on...